The designer antibodies that did work didn’t bind to their targets particularly strongly
Then I’d say those that “did work” actually “didnt work”.
Basically they used AI to generate antibodies that didn’t work.
Not that exciting.
Then I’d say those that “did work” actually “didnt work”.
Basically they used AI to generate antibodies that didn’t work.
Not that exciting.
We’ve had computer aided drug design for the past 4 decades.
Nothing wrong with sharing the research. But calling an AI generated set of antibodies a “landmark moment” when they don’t do what we want antibodies to do is a bit… inappropriate?
The purpose of antibody development is to develop something that binds well. That’s the goal. So basically AI designed something useless.
The analogy should be that birds can fly thousands of miles when comparing with human flight